» Articles » PMID: 23860386

Nucleated Red Blood Cell Counts: an Early Predictor of Brain Injury and 2-year Outcome in Neonates with Hypoxic-ischemic Encephalopathy in the Era of Cooling-based Treatment

Overview
Journal Brain Dev
Publisher Elsevier
Specialty Neurology
Date 2013 Jul 18
PMID 23860386
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Raised nucleated red blood cell (NRBC) counts in neonates may indicate in utero hypoxia and brain damage.

Objective: The study aimed to examine the use of NRBC counts as a predictor of brain injury and neurodevelopmental outcomes in neonates with hypoxic-ischemic encephalopathy (HIE) treated under current cooling-based strategy.

Methods: Forty-three neonates with asphyxia between 2004 and 2010 were retrospectively investigated. Twenty neonates with moderate/severe HIE underwent hypothermia (HT), and 23 with mild HIE were treated in normothermia (NT). Neonates were divided into groups according to the presence of cerebral parenchymal lesions on magnetic resonance imaging (MRI) at 2 weeks after birth. All patients were followed-up neurologically for ⩾ 24 months. NRBC counts during the first 3 days were compared between groups.

Results: Eleven HT (HT-N) and 21 NT (NT-N) neonates had normal MRI, and 9 HT (HT-L) and 2 NT (NT-L) neonates had parenchymal lesions. NRBC counts, both absolute and /100 white blood cells (WBC) counts, during the first 3 days in HT-L and NT-L were significantly higher than those in HT-N and NT-N, particularly within 6 hours after birth (HT-N: 502 [0-3060]/mm(3) vs HT-L: 2765 [496-6192]; 0 [0-3417] vs NT-L: 4384 [3978-4789], median [range]). Neonates with /100 white blood cells ⩾ 6/mm(3) and absolute NRBC counts ⩾ 1324/mm(3) within 6 hours of birth had high risks of abnormal MRIs and 2-year outcomes.

Conclusions: NRBC counts can predict brain injury and neurological outcomes in cooled and non-cooled asphyxiated neonates.

Citing Articles

NRBC concentrations over time in neonates with moderate to severe neonatal encephalopathy with and without sentinel events.

Gaulee P, Bliznyuk N, Rajderkar D, Graham G, Sura L, Harris J J Perinatol. 2024; 44(8):1157-1162.

PMID: 38287136 DOI: 10.1038/s41372-024-01887-6.


Diagnostic Value and Prognostic Significance of Nucleated Red Blood Cells (NRBCs) in Selected Medical Conditions.

Pikora K, Kretowska-Grunwald A, Krawczuk-Rybak M, Sawicka-Zukowska M Cells. 2023; 12(14).

PMID: 37508482 PMC: 10378384. DOI: 10.3390/cells12141817.


Emergence role of nucleated red blood cells in molecular response evaluation for chronic myeloid leukemia.

Phan T, Vy H, Ho T, Tran V, Tran T, Pho S Int J Gen Med. 2019; 12:333-341.

PMID: 31564956 PMC: 6731972. DOI: 10.2147/IJGM.S219744.


Safety and Short-Term Outcomes of Therapeutic Hypothermia in Preterm Neonates 34-35 Weeks Gestational Age with Hypoxic-Ischemic Encephalopathy.

Rao R, Trivedi S, Vesoulis Z, Liao S, Smyser C, Mathur A J Pediatr. 2016; 183:37-42.

PMID: 27979578 PMC: 5367984. DOI: 10.1016/j.jpeds.2016.11.019.


Evaluation of nucleated red blood cell count by Sysmex XE-2100 in patients with thalassaemia or sickle cell anaemia and in neonates.

Buoro S, Vavassori M, Pipitone S, Benegiamo A, Lochis E, Fumagalli S Blood Transfus. 2015; 13(4):588-94.

PMID: 25761322 PMC: 4624534. DOI: 10.2450/2015.0283-14.